Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE

Andrew D.J. Pearson, Steven G. DuBois, Victoria Buenger, Mark W. Kieran, Kimberly Stegmaier, Pratiti Bandopadhayay, Kelly Bennett, Franck Bourdeaut, Patrick A. Brown, Louis Chesler, Jessica Clymer, Elizabeth Fox, Christopher A. French, Eva Germovsek, Francis J. Giles, Julia Glade Bender, Maureen M. Hattersley, Donna Ludwinski, Katarina Luptakova, John M. Maris, Joe McDonough, Zariana Nikolova, Malcolm A. Smith, Athanasios C. Tsiatis, Rajeev Vibhakar, Susan Weiner, Joanna S. Yi, Fred Zheng, Gilles Vassal